Thursday, January 31, 2013
Evotec AG is double dipping
into the Ivy League, this time partnering with Yale University to move early stage
research from the university's labs into late preclinical and IND-ready assets
for third parties to license. The Yale collaboration is upstream of the biotech's
2011 deal with Harvard University because
the projects are not predefined.
Lou, K.-J. SciBX 6(4); doi:10.1038/scibx.2013.80
Published online Jan. 31, 2013
1. McCallister, E. BioCentury
20(31), A9-A10; July 30, 2012
AND INSTITUTIONS MENTIONED
(Xetra:EVT), Hamburg, Germany
Harvard University, Cambridge, Mass.
Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J.
Yale University, New Haven, Conn.